Patents by Inventor Simon W. Rabkin

Simon W. Rabkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7115562
    Abstract: The present invention relates to a method of reducing cell death in a warm-blood animal wherein said cell death associated with a neurodegenerative disorder, an immune disease, a neoplastic disorder, an inflammatory disorder, or a viral disease. The method comprises administering to said animal a therapeutically effective amount of a peptide comprising amino acid sequence: Ser-Val-Asp-Val-Glu-Tyr.
    Type: Grant
    Filed: January 11, 2005
    Date of Patent: October 3, 2006
    Assignee: CV Molecular Therapeutics, Inc.
    Inventors: Gerald Krystal, Simon W. Rabkin
  • Patent number: 6841532
    Abstract: There is disclosed novel peptides, fragments or analogues thereof and polynucleotides encoding the same, obtained from streptokinase suitable for use in the amelioration of cell death and methods related thereto.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: January 11, 2005
    Assignee: CV Molecular Therapeutics, Inc.
    Inventors: Gerald Krystal, Simon W. Rabkin
  • Publication number: 20020165129
    Abstract: There is disclosed novel peptides, fragments or analogues thereof and polynucleotides encoding the same, obtained from streptokinase suitable for use in the amelioration of cell death and methods related thereto.
    Type: Application
    Filed: July 31, 2001
    Publication date: November 7, 2002
    Inventors: Gerald Krystal, Simon W. Rabkin
  • Patent number: 6348567
    Abstract: There is disclosed novel peptides, fragments or analogues thereof and polynucleotides encoding the same, obtained from streptokinase suitable for use in the amelioration of cell death and methods related thereto.
    Type: Grant
    Filed: April 19, 1999
    Date of Patent: February 19, 2002
    Assignee: CV Molecular Therapeutics Inc.
    Inventors: Gerald Krystal, Simon W. Rabkin
  • Patent number: 5917013
    Abstract: There is disclosed novel peptides, fragments or analogues thereof and polynucleotides encoding the same, derived from streptokinase suitable for use in the amelioration of cell death and methods related thereto.
    Type: Grant
    Filed: December 5, 1996
    Date of Patent: June 29, 1999
    Assignee: Simon W. Rabkin
    Inventors: Simon W. Rabkin, Gerald Krystal
  • Patent number: 5612061
    Abstract: A composition for the treatment of premenstrual syndrome comprising an effective amount of calcium, magnesium, an analgesic and a diuretic sufficient to reduce the symptoms of premenstrual syndrome.
    Type: Grant
    Filed: October 14, 1994
    Date of Patent: March 18, 1997
    Inventor: Simon W. Rabkin